Navigation Links
Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting

Four Posters Relating to Company Oncology Programs to be Presented

SOUTH SAN FRANCISCO, Calif., April 09, 2007 /PRNewswire-FirstCall/ -- Cytokinetics, Incorporated announced today that four posters containing non-clinical data will be presented at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) to be held from April 14- 18, 2007 in Los Angeles, CA. These posters are related to multiple oncology programs at Cytokinetics and will present data evaluating ispinesib, a novel inhibitor of Kinesin Spindle Protein (KSP), in models of multiple myeloma, data evaluating GSK-923295, a novel inhibitor of centrosome associated protein E (CENP-E) in both biochemical assays and in xenograft models and data from a separate, novel Cytokinetics' cell-based drug discovery program.

    Poster Presentations at 2007 AACR Annual Meeting


    Ispinesib:


     Abstract #1435:  Kinesin Spindle Protein Inhibition for the Treatment of

     Multiple Myeloma. (Poster displayed on Sunday, April 15, 2007, 1:00 PM -

     5:00 PM, PT, Poster Section 27, Poster Board 16.)


    GSK-923295:


     Abstract #1522:  GSK-923295, a Potent and Selective CENP-E Inhibitor, Has

     Broad Spectrum Activity Against Human Tumor Xenografts in Nude Mice.

    (Poster displayed on Sunday, April 15, 2007, 1:00 PM - 5:00 PM, PT, Poster

     Section 31, Poster Board 8.)


     Abstract #3179:  Detailed Biochemical Analysis of the CENP-E Inhibitor

     GSK-923295. (Poster displayed on Monday, April 16, 2007, 1:00 PM - 5:00

     PM, PT, Poster Section 26, Poster Board 18.)


    Cell-based Drug Discovery Program:


     Abstract #5576:  Cell-based Discovery and Anti-tumor Activity of a Novel

     Mitotic Inhibitor. (Poster displayed on Wednesday, April 18, 2007, 8:00

     AM -12:00 PM, PT, Poster Section 27, Poster Board 14.)

Ispinesib has been the subject of a broad Phase II clinical trials program unde
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
(Date:11/24/2009)...re-FirstCall/--KeryxBiopharmaceuticals,Inc.(Nasdaq...hiefExecutiveOfficer,isscheduledtopresentatthePipe...ewYorkCity. ,, Mr.Bentsur,spresentationwillbewe...beaccessiblefromtheInvestorInformationpageoftheCom...ivedversionofthewebcastwillbeavailablefollowingthe...
(Date:11/23/2009)...swire-USNewswire/--FebeDurango-Rueda,52,aColombian...ginaschemetodefraudtheExport-ImportBankoftheUnited...stantAttorneyGeneraloftheCriminalDivisionLannyA.Br...eEx-ImBank,OfficeoftheInspectorGeneral. ,, Dura...istrictCourtinWashingtontoaone-countcriminalinform...
(Date:11/23/2009)...ewswire-FirstCall/--BostonScientificCorporation(NY...HealthCareConference,December1-2. ,, RayElliott...tiveVicePresidentandChiefFinancialOfficer,willpart...day,December1st,beginningatapproximately9:00a.m.E....letoallinterestedpartiesatBostonScientific,swebsit...
Breaking Medicine Technology:Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million 2Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 1Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 2Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 3Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act 57556 1Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act 57556 2Gambling Addiction Expert Says Treatment Tops Prohibition 57554 1Gambling Addiction Expert Says Treatment Tops Prohibition 57554 2
...o 450 days in patients who received eith...rch 29 The investigational,antiplatelet drug pras...atistically significant reduction in the risk of c...r physicians and patients with,potentially fatal c...compared to standard therapy with clopidogrel (Pla...
...ytherapy as NeoVista Progresses wit...ch 28 NeoVista, Inc. released,today to the eye co...y,study of the company,s novel epiretinal brachyth...neration (AMD) at the 31st Annual Macula Society,M...from the study, which,was initiated by NeoVista to...
Other Medicine Technology:Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 2Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 3Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 4Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 5Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 6Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 7NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society 2NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society 3
(Date:11/24/2009)...NAPOLIS Involving family members of pediatric can...fits both the family and the medical team, accordi...study. , Riley Hospital for Children, where the...umber of hospitals nationwide routinely offering t...ents the opportunity to join their child,s medical...
(Date:11/24/2009)... ability reduced in those with undesirable blood l...24 (HealthDay News) -- Abnormal cholesterol levels...ure, a new study has found. , U.S. researchers ...l Heart, Lung, and Blood Institute,s Framingham He...4, had coronary heart disease at the start of the ...
(Date:11/24/2009)... Laser-type device to be coupled... San Diego, CA (PRWEB) November 24, 2009 -- Ente...it has initiated discussions with a manufacturer o...y laser device which shall be owned by Entest and ...es currently being developed by Entest. These ther...
(Date:11/24/2009)... Web content and Internet market...free leads through your website. , ...en another tough year for the U.S. economy. Small ...ng the strain to keep their businesses afloat and ...pping block are things like training or marketing ...
(Date:11/24/2009)... 2009Q3Financials,S-1RegistrationStatementbeingPr... ,, WESTON,Fla.,Nov.24/PRNewswire-FirstCall/--...theCompany")ispleasedtomakeavailableacurrentcorpor...ncialsonPinksheetsrecently,ASRhasbeendiligentinacc...rmbusinessplanfortheCompany. ,, Aspartofthisong...
Breaking Medicine News(10 mins):Health News:Involving family in medical rounds benefits both family and medical team 2Health News:Involving family in medical rounds benefits both family and medical team 3Health News:Involving family in medical rounds benefits both family and medical team 4Health News:Cholesterol Plays Role in Heart Failure Risk 2Health News:Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment 2Health News:We Do Web Content Offers Free Lead Generation Report 2Health News:We Do Web Content Offers Free Lead Generation Report 3Health News:American Scientific Resources Inc. Issues Corporate Update 2Health News:American Scientific Resources Inc. Issues Corporate Update 3
...an Lunden, the nation,s,longest-running morning ne...arly two decades. During her tenure she reported ...lympics, and two Royal weddings. One of the most,...national media campaigns. Lunden,s years in broad...
...welling, loose teeth and exposed bone , , ...n of people taking widely prescribed oral osteopor...e much higher than previously thought, a new study...ible," although there was a noted risk in people t...
... discovered a new syndrome associated with severe ...hich children lack sufficient infection-fighting w...e syndrome: mutations in the gene Glucose-6-phosph... an international team of scientists, composed of ...
...rsity Of Southern California, School Of Dentistry ...isphosphonates to increased jaw necrosis. The stud...t-term use of common oral osteoporosis drugs may l...A ). , Osteoporosis currently affects 10 million ...
...of salicylic acid in study participants , ... acid, the key component that gives aspirin its an... be something humans can produce on their own, a n.... This made sense because salicylic acid is a nat...
...tudy shows that people who are smokers and have a ...ificantly more likely to suffer a stroke from a br... in the December 31, 2008, online issue of Neurol...ke, called subarachnoid hemorrhage, is one of the ...
Other Medicine News:Health News:Joan Lunden Inks Three-Year Deal to Host Health Corner(R) Television Series 2Health News:Study Links Osteoporosis Drugs to Jaw Trouble 2Health News:Study Links Osteoporosis Drugs to Jaw Trouble 3Health News:Scientists identify new congenital neutropenia syndrome and causative gene mutation 2Health News:Scientists identify new congenital neutropenia syndrome and causative gene mutation 3Health News:USC dentist links Fosomax-type drugs to jaw necrosis 2Health News:Smokers with stroke in the family 6 times more likely to have stroke too 2
...ity The Equalizer 384 includes all the revolutio...and equal tip spacing, choice of two software pack...ion capabilities. In addition, this model allows y...ding and accessing many gels and for use with 384 ...
BioPette E Electronic Multi-Channel Pipettor, 10-200l
... Pick one of our pipettors up and use it. Notice ...onsright where they should beeven if youre left-ha...y designed to help avoid repetitive stress injurie... In The Palm Of Your Hand Start dispensing right ...
... Pick one of our pipettors up and use it. Notice ...onsright where they should beeven if youre left-ha...y designed to help avoid repetitive stress injurie... In The Palm Of Your Hand Start dispensing right ...
Medicine Products: